The Administration Core serves to direct and support the research and development programs of the GNL. A dedicated leadership team ensures the safe and secure operations of the laboratory, oversees programs and assesses the quality of work done, provides financial and business services, facilitates community relations and communications, ensures full compliance with select agent rules and regulations, provides information services, coordinates external program reviews and independent peer evaluations, and communicates with both UTMB administration and the NIH, NIAID Biodefense and Emerging Infectious Diseases program management. By providing a consolidated administrative support structure, the Core efficiently utilizes resources, avoids duplication of efforts by subordinate organizational elements, and serves as a single point of contact for accurate and consistent information dissemination.

Public Health Relevance

The Administration Core directs the research and development programs of the GNL, oversees the quality of work and ensures the safe and secure operations of the laboratory as well as compliance with select agent regulations. The consolidated administrative support structure efficiently utilizes resources, avoids duplication, and serves as a single point of contact for accurate and consistent information dissemination.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
National Biocontainment Laboratory Operation Cooperative Agreement (UC7)
Project #
5UC7AI094660-04
Application #
8820991
Study Section
Special Emphasis Panel (ZAI1-PRJ-M (J1))
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
4
Fiscal Year
2014
Total Cost
$5,025,501
Indirect Cost
$4,387,103
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Thi, Emily P; Lee, Amy C H; Geisbert, Joan B et al. (2016) Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nat Microbiol 1:16142
Satterfield, Benjamin A; Cross, Robert W; Fenton, Karla A et al. (2016) Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets. J Virol 90:6326-43
Agrawal, Anurodh Shankar; Ying, Tianlei; Tao, Xinrong et al. (2016) Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Sci Rep 6:31629
Santos, Rodrigo I; Hermance, Meghan E; Gelman, Benjamin B et al. (2016) Spinal Cord Ventral Horns and Lymphoid Organ Involvement in Powassan Virus Infection in a Mouse Model. Viruses 8:
Cross, Robert W; Mire, Chad E; Branco, Luis M et al. (2016) Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res 133:218-22
Mire, Chad E; Geisbert, Joan B; Agans, Krystle N et al. (2016) Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates. J Infect Dis 214:S367-S374
Mire, Chad E; Geisbert, Joan B; Agans, Krystle N et al. (2016) Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus. J Infect Dis 214:S263-S267
Cross, Robert W; Mire, Chad E; Borisevich, Viktoriya et al. (2016) The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus. J Infect Dis 214:565-9
Mire, Chad E; Geisbert, Thomas W; Feldmann, Heinz et al. (2016) Ebola virus vaccines - reality or fiction? Expert Rev Vaccines 15:1421-1430
Olsen, Michelle E; Filone, Claire Marie; Rozelle, Dan et al. (2016) Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication. MBio 7:

Showing the most recent 10 out of 52 publications